[e-med] Evolution des prix des ARV au Brésil

["remed" <c.bruneton@remed.org>]

[un intéressant article sur l'évolution des prix des ARV au Brésil.CB]

-----Message d'origine-----
De : e-drug-bounces@healthnet.org [mailto:e-drug-bounces@healthnet.org] De
la part de Nunn, Amy
Envoyé : mardi 13 novembre 2007 11:52
À : e-drug@healthnet.org
Objet : [e-drug] Evolution of Antiretroviral Drug Costs in Brazil

E-DRUG: Evolution of Antiretroviral Drug Costs in Brazil
--------------------------------------------------------

dear E-druggers,

Please find our research study entitled "Evolution of Antiretroviral Drug
Costs in Brazil in the Context of Free and Universal Access to AIDS
Treatment," published today in PLoS Medicine, at the following link: 

http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/
journal.pmed.0040305 

[The conclusion reads: 
"Despite Brazil's more costly generic ARVs, the net result of ARV price
changes has been a cost savings of approximately US$1 billion since 2001.
HAART costs have nevertheless risen steeply as Brazil has scaled up
treatment. These trends may foreshadow future AIDS treatment cost trends in
other developing countries as more people start treatment, AIDS patients
live longer and move from first-line to second and third-line treatment,
AIDS treatment becomes more complex, generic competition emerges, and newer
patented drugs become available. The specific application of the Brazilian
model to other countries will depend, however, on the strength of their
health systems, intellectual property regulations, epidemiological profiles,
AIDS treatment guidelines, and differing capacities to produce drugs
locally."]

regards

Amy Nunn, ScD
amycitanunn@gmail.com